| Themis Medicare Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530199 |
NSE Symbol : THEMISMED |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE083B01024 |
Div & Yield% : 0.44 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 29.10 |
Market Cap(₹Cr) : 1,049.94 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 76.53 | 90.13 | 77.99 | 97.58 | 71.70 | 93.81 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 76.53 | 90.13 | 77.99 | 97.58 | 71.70 | 93.81 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.67 | 1.28 | 3.24 | 1.18 | 1.55 | 1.02 |
| Total Income | 80.20 | 91.42 | 81.23 | 98.75 | 73.25 | 94.83 |
| Total Expenditure | 72.76 | 81.20 | 81.08 | 108.95 | 77.48 | 85.28 |
| PBIDT | 7.44 | 10.22 | 0.15 | -10.20 | -4.23 | 9.55 |
| Interest | 2.70 | 2.75 | 2.76 | 2.47 | 2.45 | 2.79 |
| PBDT | 4.74 | 7.47 | -2.62 | -12.67 | -6.68 | 6.76 |
| Depreciation | 2.60 | 2.59 | 2.57 | 2.55 | 2.53 | 2.54 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | -2.50 | 1.15 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.17 | 0.29 | 0.16 | 0.16 | 1.04 | -0.01 |
| Reported Profit After Tax | 1.97 | 4.58 | -5.36 | -15.37 | -7.74 | 3.08 |
| Extra-ordinary Items | 0.00 | -0.81 | 0.00 | -1.28 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.97 | 5.39 | -5.36 | -14.09 | -7.74 | 3.08 |
| EPS (Unit Curr.) | 0.21 | 0.50 | -0.58 | -1.67 | -0.84 | 0.33 |
| EPS (Adj) (Unit Curr.) | 0.21 | 0.50 | -0.58 | -1.67 | -0.84 | 0.33 |
| Calculated EPS (Unit Curr.) | 0.21 | 0.50 | -0.58 | -1.67 | -0.84 | 0.33 |
| Calculated EPS (Adj) (Unit Curr.) | 0.21 | 0.50 | -0.58 | -1.67 | -0.84 | 0.33 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.85 | 1.99 | -2.33 | -6.68 | -3.37 | 1.34 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.85 | 1.99 | -2.33 | -6.68 | -3.37 | 1.34 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.21 | 9.21 | 9.20 | 9.20 | 9.20 | 9.20 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.72 | 11.34 | 0.19 | -10.45 | -5.90 | 10.18 |
| PBDTM(%) | 6.19 | 8.29 | -3.36 | -12.98 | -9.32 | 7.21 |
| PATM(%) | 2.57 | 5.08 | -6.87 | -15.75 | -10.79 | 3.28 |
